5

I have been going through the Rhodes medical physiology and have learned about Endothelin (specifically its role in hyperplasia) and collateral vessels in slowly developed [cardiovascular disease] (CVD). This makes me wonder the following things:

  1. Why can we not avoid the scar tissue formation that plagues myocardial infarction (MI) survivors by administering Endothelin in a selective manner so as to make it only hit the type A receptors ?
  2. How plastic are heart cells?

FYI: I have no idea how the heart controls its plasticity and cell growth, but given that cancers in the heart are so rare surely the administration of endothelin would be well regulated

  • Would you mind rephrasing the question title? I'm trying to get my mind work out the meaning, but it's hard to understand. – Narusan Jun 17 '17 at 22:35
  • 1
    Sure thing, my english isnt great but ive reworded the quesiton – Confusedbyeverything Jun 17 '17 at 23:05
  • 1
    I have proposed an edit which spells out acronyms, fixes some language problems and links medical terminology to articles. Feel free to accept or reject it. – Narusan Jun 27 '17 at 11:59
  • 1
    Thanks - You see, that's the issue with acronyms: You meant cardiovascular disease, and I thought of chemical vapor deposition, although I should have guessed it from the context. – Narusan Jun 27 '17 at 14:02
  • 1
    I'm voting to close this question as off-topic because it's a theoretical question. – Graham Chiu Mar 11 '18 at 6:08

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.